Human Continuum Appoints Dr. Omar Khalid Sial, Ph.D., as its Chief Scientific Officer to Spearhead the Development of Innovative Extracellular Vesicle Topical Formulati…

New York, N.Y., Jan. 22, 2026 (GLOBE NEWSWIRE) -- Human Continuum Inc. (“HC” or “the Company”), a developer of ...

Human Continuum Appoints Dr. Tsun "Sean" Law MD, MBA as its Chief Executive Officer to Lead the Research and Development Efforts Focused on Next-Generation …

Dr. Law will lead the Company’s efforts to develop and advance an integrated platform of exosome-based therapies, topical ...